The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona

被引:14
|
作者
Herrera, Sabina [1 ]
Guelar, Ana [1 ]
Sorli, Luisa [1 ]
Vila, Joan [2 ]
Molas, Ema [1 ]
Grau, Maria [2 ]
Marrugat, Jaume [2 ]
Esteve, Erika [1 ]
Gueerri-Fernandez, Roberto [1 ]
Montero, Milagro [1 ]
Knobel, Hernando [1 ]
机构
[1] Hosp Mar, Dept Infect Dis, Barcelona 08003, Spain
[2] IMIM Hosp Mar Med Res Inst, Cardiovasc Epidemiol & Genet, Barcelona, Spain
来源
HIV CLINICAL TRIALS | 2016年 / 17卷 / 04期
关键词
Cardiovascular risk; Framingham; HIV; REGICOR; CARDIOVASCULAR RISK; MYOCARDIAL-INFARCTION; ANTIRETROVIRAL THERAPY; EUROPEAN POPULATIONS; CORONARY-DISEASE; MORTALITY-RATES; DATA-COLLECTION; TASK-FORCE; SPAIN; TRENDS;
D O I
10.1080/15284336.2016.1177266
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Cardiovascular risk (CVR) assessment helps to identify patients at high CVR. The Framingham CVR score (FRS) is the most widely used methods but may overestimate risk in regions with low incidence of cardiovascular disease. The objective was to compare the 10-year performance of the original and the adapted REGICOR - Framingham CVR functions in HIV-infected individuals. Methods: We carried out a longitudinal study of HIV-infected patients with CVR evaluation in a hospital in Barcelona between 2003 and 2013. Statistics: Risk probability was calculated using the FRAMINGHAM function and REGICOR adaptation to the Spanish population, and individuals were categorized in three groups (low, 0 < 5%; moderate, 5-10%; and high, > 10%). For each risk group, the number of events over 10 years was calculated using the Kaplan-Meier method, and the expected number of events was calculated by multiplying the frequency of participants in the group by the mean of the probabilities from the risk function. We used the X-2 goodness-of-fit test to assess agreement between observed and expected. Results: Six hundred and forty-one patients were followed up for a median of 10.2 years, and 20 ischemic heart events (IHE) were observed. The mean (95% CI) number of IHEs per 1000 person-years was 3.7 (2.06-5.27). The estimates from the Framingham and REGICOR functions were 40 and 14 IHEs, respectively. The estimate from the original Framingham function differed significantly from the observed incidence (p < 0.001), whereas that from the REGICOR-adapted function did not (p = 0.15). In terms of the number of cardiovascular events (38 events observed), the REGICOR function significantly underestimated risk (p = 0.01), whereas the estimate from the Framingham function was similar to observed (p: 0.93). Conclusions: The FRS significantly overestimates risk of IHE events in our HIV-infected patients, while the REGICOR function is a better predictor of these events. In terms of cardiovascular events, the REGICOR function significantly underestimates risk, whereas the FRS is a better estimator. We recommend using CVR scales and adjusting them to the origin of the population being studied.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [31] Chronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women
    Schwartz, Rebecca M.
    Mansoor, Ather
    Wilson, Tracey E.
    Anastos, Kathryn
    Everson-Rose, Susan A.
    Golub, Elizabeth T.
    Goparaju, Lakshmi
    Hessol, Nancy A.
    Mack, Wendy J.
    Lazar, Jason
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2012, 24 (03): : 394 - 403
  • [32] Contribution of antiretroviral therapy to cardiovascular disease risk in HIV-infected patients
    Burrowes, Shana
    Cahill, Patrick
    Kottilil, Shyamasundaran
    Bagchi, Shashwatee
    [J]. FUTURE VIROLOGY, 2016, 11 (07) : 509 - 527
  • [33] Cardiovascular disease risk factors in HIV-Infected patients in the HAART era
    Galli, M
    Ridolfo, AL
    Gervasoni, C
    [J]. HIV-ASSOCIATED CARDIOVASCULAR DISEASE: CLINICAL AND BIOLOGICAL INSIGHTS, 2001, 946 : 200 - 213
  • [34] Cardiovascular disease risk scores comparison in Serbian HIV-infected patients
    Dimitrijevic, Bozana
    Jevtovic, Djordje
    Soldatovic, Ivan
    Ranin, Jovan
    Salemovic, Dubravka
    Kusic, Jovana
    Dragovic, Gordana
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [35] Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools?
    Friis-Moller, Nina
    Worm, Signe Westring
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (08) : 1082 - 1084
  • [36] Effects of pregnancy on endothelial function and cardiovascular disease risk in HIV-infected women
    Luzi, Kety
    Eckard, Allison Ross
    Lattanzi, Antonella
    Zona, Stefano
    Modena, Maria G.
    Facchinetti, Fabio
    Guaraldi, Giovanni
    [J]. PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2013, 3 (02) : 105 - 110
  • [37] Assessment of Vascular Function in HIV-Infected Patients
    Borges, Juliana P.
    Tibirica, Eduardo
    Soares, Pedro Paulo S.
    Benedito, Bruno
    Lima, Dirce B.
    Gomes, Marilia B.
    Farinatti, Paulo T. V.
    [J]. HIV CLINICAL TRIALS, 2011, 12 (04): : 215 - 221
  • [38] Thyroid function abnormalities in HIV-infected patients
    Hoffmann, Christopher J.
    Brown, Todd T.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (04) : 488 - 494
  • [39] CHEMOSENSORY FUNCTION AND DIET IN HIV-INFECTED PATIENTS
    MATTES, RD
    WYSOCKI, CJ
    GRAZIANI, A
    MACGREGOR, RR
    [J]. LARYNGOSCOPE, 1995, 105 (08): : 862 - 866
  • [40] Cardiovascular Risk Assessment in HIV Infected Patients: Framingham or Score?
    Oliveira, Joana Isabel
    Lau, Eva
    Santos, Ana Cristina
    Serrao, Rosario
    Sarmento, Antonio
    Carvalho, Davide
    Freitas, Paula
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)